Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan

NCT00613028 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma

Interventions

DRUG: Temo + Avastin
DRUG: VP-16 + Avastin

Sponsor

Duke University

Collaborators

[object Object]